Alvotech ALVO
NASDAQ ALVO
$5.17 +0.14 (+2.78%)
As of: Oct 20, 2026 · 10:42 AM EDT

Alvotech (ALVO) Non Operating Income (2022 - 2024)

Updated

Alvotech (ALVO) posted Non Operating Income of -$287.21 million for Q4 2024, compared with -$296.19 million a year earlier.

Analysis

Alvotech (ALVO) Non Operating Income (2022 - 2024) Analysis & Trends

Since Q4 2022, Alvotech has reported Non Operating Income for 4 quarters.

  • In prior years, Alvotech's Non Operating Income was -$296.19 million in FY2023, -$205.21 million in FY2022, $86.26 million in FY2021 and -$154.23 million in FY2020.
  • Quarterly Non Operating Income has run from a low of -$296.19 million in Q4 2023 to a high of -$176.75 million in Q1 2024 over five years.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Op. Inc. (Qtr)
1 Eli Lilly 1,157.82 Bn 1,126.40 Bn 19.71 Bn 269.00 Mn
2 Johnson & Johnson 625.08 Bn 543.61 Bn 17.26 Bn -
3 AbbVie 509.83 Bn 482.94 Bn 12.70 Bn -
4 Merck 365.85 Bn 320.23 Bn 12.21 Bn -
5 Novartis Ag 296.26 Bn 260.25 Bn 11.24 Bn -
6 Astrazeneca 260.41 Bn 234.09 Bn 12.86 Bn -
7 Amgen 235.13 Bn 190.53 Bn 7.24 Bn -73.00 Mn
8 Gilead Sciences 192.91 Bn 167.10 Bn 6.22 Bn 387.00 Mn
9 Pfizer 170.83 Bn 117.47 Bn 10.94 Bn -
10 Alvotech 1.50 Bn 1.06 Bn 2.56 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 -287.21 Mn
Mar 31, 2024 -176.75 Mn
Dec 31, 2023 -296.19 Mn
Mar 31, 2023 -209.29 Mn
Dec 31, 2022 -205.21 Mn
Mar 31, 2022 -22.87 Mn
API Access

Alvotech Non Operating Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-income&ticker=ALVO&period=max&api_key=YOUR_API_KEY